MECP2 and Rett syndrome: Recent work on mouse models of other neurodevelopmental disorders, such as Rett syndrome (RTT), have demonstrated the possibility of a reversal of disease via adult post-symptomatic re-expression of MECP2, the gene disrupted in RTT [8].